The Efficacy and Safety of IBI-10090 for the Treatment of Inflammation Associated With Cataract Surgery
Clinical trial NCT02006888 · COMPLETED
Trial details
- NCT number
- NCT02006888
- Sponsor
- ICON Bioscience Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2014-10-01
- Enrollment
- 394
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.